Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Temozolomide and Radiation Therapy in Treating Patients With Gliomas

ClinicalTrials.gov ID: NCT00114140

Public ClinicalTrials.gov record NCT00114140. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 30, 2026, 4:44 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase II Study of a Temozolomide-Based Chemoradiotherapy Regimen for High-Risk Low-Grade Gliomas

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

RATIONALE: Drugs used in chemotherapy, such as temozolomide, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Radiation therapy uses high-energy x-rays to kill tumor cells. Giving temozolomide together with radiation therapy may kill more tumor cells. PURPOSE: This phase II trial is studying how well giving temozolomide together with radiation therapy works in treating patients with low-grade gliomas.

Study identification

NCT ID
NCT00114140
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Enrollment
136 participants

Conditions and interventions

Interventions

Drug · Radiation

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 2005 (Type not available)
Primary completion
Feb 2013 (Actual)
Completion
May 20, 2022 (Actual)
Last update posted
Jul 8, 2024

2005 – 2022

United States locations

U.S. sites
45
U.S. states
20
U.S. cities
41
Facility City State ZIP Site status
Arizona Oncology Services Foundation Phoenix Arizona 85013 —
USC/Norris Comprehensive Cancer Center and Hospital Los Angeles California 90089-9181 —
CCOP - Christiana Care Health Services Newark Delaware 19713 —
University of Florida Shands Cancer Center Gainesville Florida 32610-0232 —
Baptist Cancer Institute - Jacksonville Jacksonville Florida 32207 —
Integrated Community Oncology Network at Southside Cancer Center Jacksonville Florida 32207 —
Mayo Clinic - Jacksonville Jacksonville Florida 32224 —
Baptist Medical Center South Jacksonville Florida 32258 —
Integrated Community Oncology Network Jacksonville Beach Florida 32250 —
Integrated Community Oncology Network - Orange Park Orange Park Florida 32073 —
Florida Cancer Center - Palatka Palatka Florida 32177 —
Flagler Cancer Center Saint Augustine Florida 32086 —
University of Chicago Cancer Research Center Chicago Illinois 60637-1470 —
DeCesaris Cancer Institute at Anne Arundel Medical Center Annapolis Maryland 21401 —
Greenebaum Cancer Center at University of Maryland Medical Center Baltimore Maryland 21201 —
University of Michigan Comprehensive Cancer Center Ann Arbor Michigan 48109-0942 —
Josephine Ford Cancer Center at Henry Ford Hospital Detroit Michigan 48202 —
West Michigan Cancer Center Kalamazoo Michigan 49007-3731 —
Sparrow Regional Cancer Center Lansing Michigan 48912-1811 —
Mayo Clinic Cancer Center Rochester Minnesota 55905 —
CCOP - Kansas City Kansas City Missouri 64131 —
Methodist Estabrook Cancer Center Omaha Nebraska 68114 —
Norris Cotton Cancer Center at Dartmouth-Hitchcock Medical Center Lebanon New Hampshire 03756-0002 —
Roswell Park Cancer Institute Buffalo New York 14263-0001 —
Mission Hospitals - Memorial Campus Asheville North Carolina 28801 —
Summa Center for Cancer Care at Akron City Hospital Akron Ohio 44309-2090 —
Aultman Cancer Center at Aultman Hospital Canton Ohio 44710-1799 —
Cleveland Clinic Taussig Cancer Center Cleveland Ohio 44195 —
Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Medical Center Columbus Ohio 43210-1240 —
Cancer Research UK Medical Oncology Unit at Churchill Hospital & Weatherall Institute of Molecular Medicine - Oxford Salem Ohio 44460 —
Cancer Treatment Center Wooster Ohio 44691 —
Rosenfeld Cancer Center at Abington Memorial Hospital Abington Pennsylvania 19001 —
Penn State Cancer Institute at Milton S. Hershey Medical Center Hershey Pennsylvania 17033-0850 —
Kimmel Cancer Center at Thomas Jefferson University - Philadelphia Philadelphia Pennsylvania 19107-5541 —
CCOP - Upstate Carolina Spartanburg South Carolina 29303 —
Rapid City Regional Hospital Rapid City South Dakota 57701 —
Jon and Karen Huntsman Cancer Center at Intermountain Medical Center Murray Utah 84157 —
Dixie Regional Medical Center - East Campus St. George Utah 84770 —
University Cancer Center at University of Washington Medical Center Seattle Washington 98195-6043 —
Green Bay Oncology, Limited at St. Vincent Hospital Regional Cancer Center Green Bay Wisconsin 54301-3526 —
St. Vincent Hospital Regional Cancer Center Green Bay Wisconsin 54307-3508 —
Gundersen Lutheran Center for Cancer and Blood La Crosse Wisconsin 54601 —
University of Wisconsin Paul P. Carbone Comprehensive Cancer Center Madison Wisconsin 53792-6164 —
Bay Area Cancer Care Center at Bay Area Medical Center Marinette Wisconsin 54143 —
Medical College of Wisconsin Cancer Center Milwaukee Wisconsin 53226 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 2 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00114140, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 8, 2024 · Synced Oct 30, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00114140 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →